Modern Healthcare Technology Holdings Limited (HK:0919)
:0919
Want to see HK:0919 full AI Analyst Report?
0919 Stock Chart & Stats
HK$0.08
HK$0.00(0.00%)
At close: 4:00 PM EST
HK$0.08
HK$0.00(0.00%)
Day’s Range― - ―
52-Week RangeHK$0.07 - HK$0.12
Previous CloseN/A
Volume392.00K
Average Volume (3M)71.60K
Market Cap
HK$78.69M
Enterprise Value-HK$139.98M
Total Cash (Recent Filing)HK$301.73M
Total Debt (Recent Filing)HK$62.90M
Price to Earnings (P/E)2.6
Beta-0.07
Next Earnings
Jul 01, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)<0.01
Shares Outstanding904,483,950
10 Day Avg. Volume65,200
30 Day Avg. Volume71,600
Financial Highlights & Ratios
PEG Ratio0.28
Price to Book (P/B)0.36
Price to Sales (P/S)0.15
P/FCF Ratio0.50
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Improved LeverageImproved debt-to-equity indicates better leverage management, lowering financial risk and interest burden. Over the next several months this boosts financial flexibility to fund operations, capex or strategic initiatives and strengthens balance-sheet resilience.
Free Cash Flow GrowthSustained free cash flow growth demonstrates the business can generate cash above required investments. This durable cash generation supports debt reduction, reinvestment or shareholder returns without reliance on volatile accounting earnings.
Healthy Gross MarginsHealthy gross margins imply structural pricing power or efficient COGS, enabling the company to absorb SG&A pressure or competitive pricing. This underpins margin sustainability and provides operating leverage as revenue stabilizes or grows.
Bears Say
Declining RevenueOngoing revenue decline erodes scale, reduces fixed-cost absorption and limits reinvestment capacity. If the negative top-line trend continues over months it will pressure margins, reduce market share resilience and constrain long-term growth options.
Negative Return On EquityNegative ROE shows the company is not generating acceptable returns on shareholders' capital. Persistently negative ROE constrains funding options, weakens investor confidence, and signals underlying profitability issues that must be corrected structurally.
Declining Operating MarginsSignificant declines in EBIT and EBITDA margins point to deteriorating operational efficiency or rising operating costs. This reduces sustainable cash generation and indicates management needs to address cost structure or revenue mix to restore durable profitability.
Modern Healthcare Technology Holdings Limited News
0919 FAQ
What was Modern Healthcare Technology Holdings Limited’s price range in the past 12 months?
Modern Healthcare Technology Holdings Limited lowest stock price was HK$0.07 and its highest was HK$0.12 in the past 12 months.
What is Modern Healthcare Technology Holdings Limited’s market cap?
Modern Healthcare Technology Holdings Limited’s market cap is HK$78.69M.
When is Modern Healthcare Technology Holdings Limited’s upcoming earnings report date?
Modern Healthcare Technology Holdings Limited’s upcoming earnings report date is Jul 01, 2026 which is in 61 days.
How were Modern Healthcare Technology Holdings Limited’s earnings last quarter?
Modern Healthcare Technology Holdings Limited released its earnings results on Nov 28, 2025. The company reported HK$0.007 earnings per share for the quarter, beating the consensus estimate of N/A by HK$0.007.
Is Modern Healthcare Technology Holdings Limited overvalued?
According to Wall Street analysts Modern Healthcare Technology Holdings Limited’s price is currently Overvalued.
Does Modern Healthcare Technology Holdings Limited pay dividends?
Modern Healthcare Technology Holdings Limited pays a Notavailable dividend of HK$0.013 which represents an annual dividend yield of N/A. See more information on Modern Healthcare Technology Holdings Limited dividends here
What is Modern Healthcare Technology Holdings Limited’s EPS estimate?
Modern Healthcare Technology Holdings Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Modern Healthcare Technology Holdings Limited have?
Modern Healthcare Technology Holdings Limited has 904,483,950 shares outstanding.
What happened to Modern Healthcare Technology Holdings Limited’s price movement after its last earnings report?
Modern Healthcare Technology Holdings Limited reported an EPS of HK$0.007 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went up 1.351%.
Which hedge fund is a major shareholder of Modern Healthcare Technology Holdings Limited?
Currently, no hedge funds are holding shares in HK:0919
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Modern Healthcare Technology Holdings Limited
Modern Healthcare Technology Holdings Limited, an investment holding company, provides beauty and wellness services in Hong Kong, the People's Republic of China, Singapore, and Australia. The company operates in two segments, Beauty and Wellness Services, and Skincare and Wellness Products. It offers beauty and facial services; aesthetics services, such as skincare treatment, professional consultation, skin care and anti-ageing, and referral services on plastic reconstruction; slimming services, including weight management programs; and spa and massage services comprising resplendent bathroom furnishings and a hydrotherapeutic pool, as well as foot spa, foot treatment, and foot massage services. The company also sells skincare and wellness products under the be, FERRECARE, p.e.n, Y.U.E., Advanced Natural, Malu Wilz, Byotea, Care Plus, Cellnoc, Mu-lan Spa, Cellnoc, Veribe, Castille, Dr Plus, Eclat du teint, and Natural Care brand names. In addition, it provides franchise and trademark services in relation to beautification and gymnastic services; advertising services; maid agency services; and management services, as well as food and beverage services. As of March 31, 2022, the company had 30 service centers in Hong Kong; 3 service centers in Mainland China; and 7 service centers in Singapore, as well as 8 be Beauty Shop outlets. Modern Healthcare Technology Holdings Limited is headquartered in Kowloon Bay, Hong Kong.
Technical Analysis
Anxian Yuan China Holdings Limited
―
Miricor Enterprises Holdings Ltd
―
China Wan Tong Yuan (Holdings) Ltd.
―
Sino-Life Group Limited
―
Fameglow Holdings Limited
―